PMID- 10588814 OWN - NLM STAT- MEDLINE DCOM- 20000214 LR - 20190709 IS - 0022-0795 (Print) IS - 0022-0795 (Linking) VI - 163 IP - 3 DP - 1999 Dec TI - Involvement of inducible nitric oxide synthase in stress-impaired testicular steroidogenesis. PG - 409-16 AB - The immobilization stress induces an acute inhibition of testicular steroidogenesis that is mediated by the nitric oxide (NO) signaling pathway. Here we compared the effects of 2-h immobilization stress on in vivo and in vitro rat steroidogenesis at two time points, 0 h and 6 h after the end of the stress session. As expected, serum androgens and human chorionic gonadotropin (hCG)-stimulated progesterone and testosterone production by testicular tissue were inhibited at 0 h, and also at the 6-h time point. Both the acute and sustained inhibitions of in vitro steroidogenesis were accompanied by a significant increase in nitrite, a stable oxidation product of NO. To clarify which subtype of NO synthase (NOS) (constitutive (cNOS) or inducible (iNOS)) participates in down-regulation of testicular steroidogenesis, aminoguanidine hydrochloride (AG), a selective iNOS inhibitor, was employed. Intratesticular injection of AG prevented the sustained, but not the acute, stress-induced decrease in serum testosterone. When added in vitro, it also prevented the sustained decrease in steroid production and increase in nitrite production by testicular tissue, both in a dose-dependent manner and with EC microM. Furthermore, AG added in vivo and in vitro effectively blocked the sustained decrease in 3beta-hydroxysteroid dehydrogenase (3betaHSD) and 17alpha-hydroxylase/C17-20 lyase (P450c17) activities. In all concentrations employed, AG did not affect serum androgens and in vitro steroid and nitrite production in unstressed animals. These results indicate that the NO signaling pathway participates in acute and sustained stress-induced down-regulation of testicular steroidogenesis, presumably through its direct action on 3betaHSD and P450c17. The acute NO production is controlled by cNOS and the sustained production of this messenger is controlled by iNOS. FAU - Kostic, T S AU - Kostic TS AD - Institute of Biology, Faculty of Sciences, University of Novi Sad, 21000 Novi Sad, Yugoslavia. stankosf@helix.nih.gov FAU - Andric, S A AU - Andric SA FAU - Maric, D AU - Maric D FAU - Stojilkovic, S S AU - Stojilkovic SS FAU - Kovacevic, R AU - Kovacevic R LA - eng PT - Journal Article PL - England TA - J Endocrinol JT - The Journal of endocrinology JID - 0375363 RN - 0 (Enzyme Inhibitors) RN - 0 (Guanidines) RN - 0 (Nitrites) RN - 08J2K08A3Y (Dihydrotestosterone) RN - 3XMK78S47O (Testosterone) RN - 4G7DS2Q64Y (Progesterone) RN - EC 1.14.13.39 (Nitric Oxide Synthase) RN - EC 1.14.13.39 (Nitric Oxide Synthase Type II) RN - EC 1.14.13.39 (Nitric Oxide Synthase Type III) RN - EC 1.14.13.39 (Nos2 protein, rat) RN - EC 1.14.13.39 (Nos3 protein, rat) RN - SCQ4EZQ113 (pimagedine) SB - IM MH - Animals MH - Dihydrotestosterone/metabolism MH - Enzyme Inhibitors/pharmacology MH - Guanidines/pharmacology MH - Male MH - Nitric Oxide Synthase/antagonists & inhibitors/*metabolism MH - Nitric Oxide Synthase Type II MH - Nitric Oxide Synthase Type III MH - Nitrites/metabolism MH - Progesterone/metabolism MH - Rats MH - Rats, Wistar MH - Restraint, Physical MH - *Signal Transduction MH - Statistics, Nonparametric MH - Stress, Psychological/*metabolism MH - Testis/*drug effects/metabolism MH - Testosterone/*metabolism MH - Time Factors EDAT- 1999/12/10 09:00 MHDA- 2000/02/19 09:00 CRDT- 1999/12/10 09:00 PHST- 1999/12/10 09:00 [pubmed] PHST- 2000/02/19 09:00 [medline] PHST- 1999/12/10 09:00 [entrez] AID - JOE03378 [pii] AID - 10.1677/joe.0.1630409 [doi] PST - ppublish SO - J Endocrinol. 1999 Dec;163(3):409-16. doi: 10.1677/joe.0.1630409.